Biologic treatment for psoriasis is unlikely to facilitate psoriatic arthritis development

J Am Acad Dermatol. 2023 Jan;88(1):e57-e58. doi: 10.1016/j.jaad.2022.09.044. Epub 2022 Oct 4.

Authors

Miao Chen¹, Sheng-Ming Dai²

Affiliations

¹ Department of Rheumatology and Immunology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
² Department of Rheumatology and Immunology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: shengmingdai@163.com.

PMID: 36202144
DOI: 10.1016/j.jaad.2022.09.044

No abstract available

Keywords: PsA; biologic treatment; diagnosis; epidemiology; incidence; psoriasis; psoriatic arthritis.

Publication types

Letter
Comment

MeSH terms

Arthritis, Psoriatic* / drug therapy
Biological Products* / adverse effects
Humans
Psoriasis* / complications
Psoriasis* / drug therapy
Surveys and Questionnaires

Substances

Biological Products